Before travel to areas with high TB prevalence, what testing is recommended and when should it be repeated if negative?

Before travel to areas with high TB prevalence, what testing is recommended and when should it be repeated if negative?

• A. TB skin test or IGRA prior to leaving; repeat 8-10 weeks after returning
• B. Chest X-ray prior to leaving; repeat annually
• C. No testing is required
• D. HIV test prior to leaving; repeat after 6 months

Answer: (A)

The key idea is screening for latent TB infection when there’s potential exposure from travel to areas with higher TB prevalence, and timing the test to catch recent infection. Do a TB skin test or an IGRA before leaving to establish a baseline. If that baseline is negative and there are no signs of active disease, retesting about 8–10 weeks after returning is recommended to detect a new infection acquired during travel, since the conversion window for TB can take several weeks to become detectable. A negative retest at that point supports no latent infection from the trip, while a positive retest would lead to further evaluation and possible treatment for latent TB. Chest X-ray isn’t used for routine latent TB screening (it’s used to evaluate suspected or active disease). An HIV test isn’t part of this specific TB exposure testing approach.

The key idea is screening for latent TB infection when there’s potential exposure from travel to areas with higher TB prevalence, and timing the test to catch recent infection.

Do a TB skin test or an IGRA before leaving to establish a baseline. If that baseline is negative and there are no signs of active disease, retesting about 8–10 weeks after returning is recommended to detect a new infection acquired during travel, since the conversion window for TB can take several weeks to become detectable. A negative retest at that point supports no latent infection from the trip, while a positive retest would lead to further evaluation and possible treatment for latent TB.

Chest X-ray isn’t used for routine latent TB screening (it’s used to evaluate suspected or active disease). An HIV test isn’t part of this specific TB exposure testing approach.